Home FDA labels 6b06a2a1-91d7-492c-8437-64c4fe5470f2 FDA label 6b06a2a1-91d7-492c-8437-64c4fe5470f2 openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID 405372a1-83bc-4843-b1b2-bd8ff2f83f87
SPL ID 6b06a2a1-91d7-492c-8437-64c4fe5470f2
Version 3
Effective date 2011-12-22
Source export date 2026-10-12
Source partition 10
Source file https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 02:36:06 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings and cautions 5 WARNINGS AND PRECAUTIONS Acute renal failure: Cases of acute renal failure have been reported in patients with underlying renal disease who have received inappropriately high doses of famciclovir for their level of renal function. Dosage reduction is recommended when administering famciclovir to patients with renal impairment [ see Dosage and Administration ( 2.3 ), Use in Specific Populations ( 8.6 ) ] . Acute renal failure: May occur in patients with underlying renal disease who receive higher than recommended doses of famciclovir for their level of renal function. Reduce dosage in patients with renal impairment ( 2.3 , 8.6 )
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 3 matching rows.
adverse reactions 6 ADVERSE REACTIONS Acute renal failure is discussed in greater detail in other sections of the label [ see Warnings and Precautions ( 5 ) ] . The most common adverse events reported in at least 1 indication by > 10% of adult patients treated with famciclovir are headache and nausea. The most common adverse events reported in at least one indication by >10% of adult patients are headache and nausea. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact TEVA USA, PHARMACOVIGILACE at 1-888-838-2872, X6351 or drug.safety@tevausa.com; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience in Adult Patients Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. Immunocompetent patients: The safety of famciclovir has been evaluated in active- and placebo-controlled clinical studies involving 816 famciclovir-treated patients with herpes zoster (famciclovir, 250 mg three times daily to 750 mg three times daily); 163 famciclovir-treated patients with recurrent genital herpes (famciclovir, 1000 mg twice daily); 1,197 patients with recurrent genital herpes treated with famciclovir as suppressive therapy (125 mg once daily to 250 mg three times daily) of which 570 patients received famciclovir (open-labeled and/or double-blind) for at least 10 months; and 447 famciclovir-treated patients with herpes labialis (famciclovir, 1500 mg once daily or 750 mg twice daily). Table 2 lists selected adverse events. Table 2: Selected Adverse Events (all Grades and Without Regard to Causality) Reported by ≥ 2% of Patients in Placebo-Controlled Famcicovir Trials Incidence Herpes Zoster Recurrent Genital Herpes 1 day of treatment Genital Herpes- Supression Herpes Labialis Event Famciclovir Placebo Famciclovir Placebo Famciclovir Placebo Famciclovir Placebo (n = 273) (n = 146) (n = 163) (n = 166) (n = 458) (n = 63) (n = 447) (n = 254) % % % % % % % % Nervous System Headache 22.7 17.8 13.5 5.4 39.3 42.9 8.5 6.7 Paresthesia 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 Migraine 0.7 0.7 0.6 0.6 3.1 0.0 0.2 0.0 Gastrointestinal Nausea 12.5 11.6 2.5 3.6 7.2 9.5 2.2 3.9 Diarrhea 7.7 4.8 4.9 1.2 9.0 9.5 1.6 0.8 Vomiting 4.8 3.4 1.2 0.6 3.1 1.6 0.7 0.0 Flatulence 1.5 0.7 0.6 0.0 4.8 1.6 0.2 0.0 Abdominal Pain 1.1 3.4 0.0 1.2 7.9 7.9 0.2 0.4 Body as a Whole Fatigue 4.4 3.4 0.6 0.0 4.8 3.2 1.6 0.4 Skin and Appendages Pruritus 3.7 2.7 0.0 0.6 2.2 0.0 0.0 0.0 Rash 0.4 0.7 0.0 0.0 3.3 1.6 0.0 0.0 Reproductive (Female) Dysmenorrhea 0.0 0.7 1.8 0.6 7.6 6.3 0.4 0.0 Table 3 lists selected laboratory abnormalities in genital herpes suppression trials. Table 3: Selected Laboratory Abnormalities in Genital Herpes Suppression Studies Parameter Famciclovir (n = 660) n values represent the minimum number of patients assessed for each laboratory parameter. % Placebo (n = 210) % Anemia (< 0.8 x NRL) 0.1 0.0 Leukopenia (< 0.75 x NRL) 1.3 0.9 Neutropenia (< 0.8 x NRL) 3.2 1.5 AST (SGOT) (> 2 x NRH) 2.3 1.2 ALT (SGPT) (> 2 x NRH) 3.2 1.5 Total Bilirubin (> 1.5 x NRH) 1.9 1.2 Serum Creatinine (> 1.5 x NRH) 0.2 0.3 Amylase (> 1.5 x NRH) 1.5 1.9 Lipase (> 1.5 x NRH) 4.9 4.7 NRH = Normal Range High. NRL = Normal Range Low. HIV-infected patients: In HIV-infected patients, the most frequently reported adverse events for famciclovir (500 mg twice daily; n = 150) and acyclovir (400 mg, 5x/day; n = 143), respectively, were headache (17% vs. 15%), nausea (11% vs. 13%), diarrhea (7% vs. 11%), vomiting (5% vs. 4%), fatigue (4% vs. 2%), and abdominal pain (3% vs. 6%). 6.2 Postmarketing Experience The adverse events listed below have been reported during post-approval use of famciclovir. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure: Blood and lymphatic system disorders: Thrombocytopenia Hepatobiliary disorders : Abnormal liver function tests, cholestatic jaundice Nervous system disorders : Dizziness, somnolence Psychiatric disorders : Confusion (including delirium, disorientation, and confusional state occurring predominantly in the elderly), hallucinations Skin and subcutaneous tissue disorders : Urticaria, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis
adverse reactions table <table border="single" width="525" ID="id_f93f7dd7-8b16-4e8c-829e-0f085f91a90e"> <caption ID="id_ec0ee802-ee9e-410c-a024-3700e9734782">Table 2: Selected Adverse Events (all Grades and Without Regard to Causality) Reported by ≥ 2% of Patients in Placebo-Controlled Famcicovir Trials </caption> <col width="13.5%"/> <col width="12.4%"/> <col width="8.8%"/> <col width="12.4%"/> <col width="8.8%"/> <col width="12.6%"/> <col width="9.1%"/> <col width="13.3%"/> <col width="9.1%"/> <tbody> <tr ID="id_ce998490-0de1-41ea-85eb-6206bd071cba"> <td align="center" valign="top" colspan="9" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Incidence</content> </td> </tr> <tr ID="id_d4605c52-a23e-45dd-8551-218465bac570"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"/> <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"> <content styleCode="bold">Herpes Zoster </content> </td> <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"> <content styleCode="bold">Recurrent Genital Herpes<footnote ID="id-fb1fa213-e500-4cf6-8074-8dd5de657822">1 day of treatment</footnote> </content> </td> <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"> <content styleCode="bold">Genital Herpes- Supression </content> </td> <td align="center" valign="top" colspan="2" styleCode="Botrule Rrule"> <content styleCode="bold">Herpes Labialis<content styleCode="bold"> <footnoteRef IDREF="id-fb1fa213-e500-4cf6-8074-8dd5de657822"/> </content> </content> </td> </tr> <tr ID="id_acf7fab1-cc2e-4862-9839-fca2eb192b0f"> <td align="left" valign="top" rowspan="3" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Event</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Famciclovir</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Placebo</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Famciclovir</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Placebo</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Famciclovir</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Placebo</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Famciclovir</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">Placebo</content> </td> </tr> <tr ID="id_31acea8b-6cff-4c7d-ad85-244b563324d4"> <td align="center" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">(n = 273)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 146)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 163)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 166)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 458)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 63)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 447)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">(n = 254)</content> </td> </tr> <tr ID="id_d3fbe4ea-70cf-44a0-ac07-cb6ed4baf961"> <td align="center" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"> <content styleCode="bold">%</content> </td> </tr> <tr ID="id_efffc7a6-732f-45ba-95a8-15df55b9d6d6"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Nervous System</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> </tr> <tr ID="id_1d2e5c6f-cc5f-4b1e-8e91-a57536752b93"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Headache </td> <td align="center" valign="top" styleCode="Botrule Rrule">22.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">17.8</td> <td align="center" valign="top" styleCode="Botrule Rrule">13.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">5.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">39.3</td> <td align="center" valign="top" styleCode="Botrule Rrule">42.9</td> <td align="center" valign="top" styleCode="Botrule Rrule">8.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">6.7</td> </tr> <tr ID="id_21a6c00c-9b97-4564-a043-33cf830dea79"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Paresthesia </td> <td align="center" valign="top" styleCode="Botrule Rrule">2.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.9</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_0feb5975-99d5-431e-80ff-c48c4ce1b167"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Migraine </td> <td align="center" valign="top" styleCode="Botrule Rrule">0.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.1</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_e56e4e97-8947-428e-8054-70cb63d49337"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Gastrointestinal</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> </tr> <tr ID="id_d40d8889-13b3-4f75-ae33-a8feea1408e8"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Nausea </td> <td align="center" valign="top" styleCode="Botrule Rrule">12.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">11.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">2.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">7.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">9.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">2.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.9</td> </tr> <tr ID="id_823a2e4d-3a23-4f04-90c8-65af800ad6e5"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Diarrhea </td> <td align="center" valign="top" styleCode="Botrule Rrule">7.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">4.8</td> <td align="center" valign="top" styleCode="Botrule Rrule">4.9</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">9.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">9.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.8</td> </tr> <tr ID="id_e4f99d6a-282c-4512-a896-e993701689fa"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Vomiting </td> <td align="center" valign="top" styleCode="Botrule Rrule">4.8</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.1</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_6d0fc348-55d0-4c79-b243-57d5fc10d77f"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Flatulence </td> <td align="center" valign="top" styleCode="Botrule Rrule">1.5</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">4.8</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_0fdcb056-b1c6-4ea1-97e6-4640dbf21ffb"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Abdominal Pain </td> <td align="center" valign="top" styleCode="Botrule Rrule">1.1</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">7.9</td> <td align="center" valign="top" styleCode="Botrule Rrule">7.9</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.4</td> </tr> <tr ID="id_f2e59740-1aaa-4abb-891a-8da85f107022"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Body as a Whole</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> </tr> <tr ID="id_98f8e9bf-d2ef-44c1-9513-eb5555c8828c"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Fatigue </td> <td align="center" valign="top" styleCode="Botrule Rrule">4.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">4.8</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.4</td> </tr> <tr ID="id_961b95b4-a314-49cc-aa33-dadb18d8a342"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Skin and Appendages</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> </tr> <tr ID="id_767327e2-d1ec-43d1-a198-42ec1ae77fa7"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Pruritus </td> <td align="center" valign="top" styleCode="Botrule Rrule">3.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">2.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">2.2</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_14a12d56-e57e-489c-9984-8fca07a24699"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Rash </td> <td align="center" valign="top" styleCode="Botrule Rrule">0.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.7</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">3.3</td> <td align="center" valign="top" styleCode="Botrule Rrule">1.6</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> <tr ID="id_a110a735-6836-411e-b76d-28b44650cd34"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule"> <content styleCode="bold">Reproductive (Female)</content> </td> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> <td align="center" valign="top" styleCode="Botrule Rrule"/> </tr> <tr ID="id_c48df2fc-ab79-45f7-92a5-c3c8bbac4411"> <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dysmenorrhea </td> <td align="center" valign="top" styleCode="Rrule">0.0</td> <td align="center" valign="top" styleCode="Rrule">0.7</td> <td align="center" valign="top" styleCode="Rrule">1.8</td> <td align="center" valign="top" styleCode="Rrule">0.6</td> <td align="center" valign="top" styleCode="Rrule">7.6</td> <td align="center" valign="top" styleCode="Rrule">6.3</td> <td align="center" valign="top" styleCode="Rrule">0.4</td> <td align="center" valign="top" styleCode="Botrule Rrule">0.0</td> </tr> </tbody> </table>
adverse reactions table <table border="single" width="344" ID="id_e818e094-9594-44fd-8e8f-2fbaaefa006d"> <caption ID="id_2ec05c5f-b997-42ca-a39c-02097624bf81">Table 3: Selected Laboratory Abnormalities in Genital Herpes Suppression Studies </caption> <col width="54.7%"/> <col width="22.7%"/> <col width="22.7%"/> <tbody> <tr ID="id_11d61a6a-4d2f-49a0-81e1-6e1a13eec050"> <td align="left" valign="top" styleCode="Toprule Botrule Lrule"> <content styleCode="bold">Parameter</content> </td> <td align="center" valign="middle" styleCode="Botrule"> <content styleCode="bold">Famciclovir (n = 660)</content> <footnote ID="id-f58b71c3-c5a7-4a0b-9844-94936cb25508">n values represent the minimum number of patients assessed for each laboratory parameter. </footnote> <content styleCode="bold"> %</content> </td> <td align="center" valign="middle" styleCode="Botrule Rrule"> <content styleCode="bold">Placebo (n = 210)<footnoteRef IDREF="id-f58b71c3-c5a7-4a0b-9844-94936cb25508"/> </content> <content styleCode="bold"> %</content> </td> </tr> <tr ID="id_e4e8b385-5c1d-490c-8b2e-ac923b470a16"> <td align="left" valign="middle" styleCode="Lrule Botrule">Anemia (< 0.8 x NRL) </td> <td align="center" valign="middle" styleCode="Botrule">0.1 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">0.0 </td> </tr> <tr ID="id_8784d933-a5cb-4a16-8f85-d0dea2254d72"> <td align="left" valign="middle" styleCode="Lrule Botrule">Leukopenia (< 0.75 x NRL) </td> <td align="center" valign="middle" styleCode="Botrule">1.3 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">0.9 </td> </tr> <tr ID="id_c20ff5bd-11c4-4d22-8d00-b8b37652b484"> <td align="left" valign="middle" styleCode="Lrule Botrule">Neutropenia (< 0.8 x NRL) </td> <td align="center" valign="middle" styleCode="Botrule">3.2 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">1.5 </td> </tr> <tr ID="id_f8fdc01e-3006-4a0e-a23e-4794982ad04b"> <td align="left" valign="middle" styleCode="Lrule Botrule">AST (SGOT) (> 2 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">2.3 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">1.2 </td> </tr> <tr ID="id_b5142868-2f53-42ba-88f7-6f27d9cd6081"> <td align="left" valign="middle" styleCode="Lrule Botrule">ALT (SGPT) (> 2 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">3.2 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">1.5 </td> </tr> <tr ID="id_7a2d587e-6c0b-410b-9d80-527ed193d900"> <td align="left" valign="middle" styleCode="Lrule Botrule">Total Bilirubin (> 1.5 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">1.9 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">1.2 </td> </tr> <tr ID="id_c0df6013-b933-4cd3-af93-9e5e95f1181f"> <td align="left" valign="middle" styleCode="Lrule Botrule">Serum Creatinine (> 1.5 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">0.2 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">0.3 </td> </tr> <tr ID="id_bd1ec768-a10b-4aea-9639-ce49a1d33316"> <td align="left" valign="middle" styleCode="Lrule Botrule">Amylase (> 1.5 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">1.5 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">1.9 </td> </tr> <tr ID="id_5a69145b-f2a8-4da1-af2b-6baad4de6b6c"> <td align="left" valign="middle" styleCode="Lrule Botrule">Lipase (> 1.5 x NRH) </td> <td align="center" valign="middle" styleCode="Botrule">4.9 </td> <td align="center" valign="middle" styleCode="Botrule Rrule">4.7 </td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.